Skip to content
Featured on Startup Fame
Back to Home

Eli Lilly news

Eli Lilly appears in 3 stories we have published between September 2026 and October 2026, mostly in our Technology and AI coverage. It is most often reported alongside Anthropic, Concordia AI and Google.

Latest development

Eli Lilly’s retatrutide reduces obstructive sleep apnea symptoms in trials

Eli Lilly’s experimental obesity drug retatrutide has demonstrated potential in reducing symptoms of obstructive sleep apnea (OSA) in recent clinical trials. The drug, which mimics multiple metabolic hormones, could offer a new treatment pathway for patients with obesity-related OSA, pending FDA approval.

26 October 2026

Covered alongside

Contact us

Have a story tip, correction or partnership idea?

Write to us at tarun.kumar@blogy.in or talk to the founder directly. We read every message.

Contact us